2023 Q3 Form 10-Q Financial Statement

#000121390023069345 Filed on August 21, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $11.33M $10.55M
YoY Change -60.0% -46.66%
Cost Of Revenue $7.716M $7.028M
YoY Change -57.57% -51.05%
Gross Profit $3.617M $3.523M
YoY Change -64.35% -35.01%
Gross Profit Margin 31.91% 33.39%
Selling, General & Admin $3.655M $6.265M
YoY Change -26.91% -33.57%
% of Gross Profit 101.07% 177.83%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.88M $8.790M
YoY Change -26.82% -45.14%
% of Gross Profit 328.48% 249.49%
Operating Expenses $19.84M $21.19M
YoY Change -10.05% -19.72%
Operating Profit -$16.22M -$17.66M
YoY Change 96.91% 442.59%
Interest Expense $515.0K $647.1K
YoY Change -66.97% -58.66%
% of Operating Profit
Other Income/Expense, Net -$3.111M $1.770M
YoY Change -5300.96% -5.07%
Pretax Income -$19.33M -$15.89M
YoY Change -9.04% 560.66%
Income Tax $1.756M
% Of Pretax Income
Net Earnings -$19.05M -$17.34M
YoY Change -8.7% 620.97%
Net Earnings / Revenue -168.08% -164.37%
Basic Earnings Per Share -$1.15 -$1.12
Diluted Earnings Per Share -$1.15 -$1.12
COMMON SHARES
Basic Shares Outstanding 16.52M shares 16.21M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.500M $5.607M
YoY Change -48.07% 124.84%
Cash & Equivalents $1.497M $5.607M
Short-Term Investments
Other Short-Term Assets $1.500M $3.585M
YoY Change -93.84% -32.82%
Inventory
Prepaid Expenses $1.547M $3.585M
Receivables $10.60M $6.404M
Other Receivables $0.00 $0.00
Total Short-Term Assets $13.65M $15.60M
YoY Change -63.43% 29.51%
LONG-TERM ASSETS
Property, Plant & Equipment $66.31M $78.53M
YoY Change -41.06% -47.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $100.0K $7.168M
YoY Change -99.57% -62.96%
Other Assets $5.100M $424.1K
YoY Change 25.08% -89.79%
Total Long-Term Assets $74.18M $89.17M
YoY Change -48.22% -50.4%
TOTAL ASSETS
Total Short-Term Assets $13.65M $15.60M
Total Long-Term Assets $74.18M $89.17M
Total Assets $87.84M $104.8M
YoY Change -51.36% -45.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $27.10M $25.34M
YoY Change -1.56% -46.14%
Accrued Expenses $1.800M $1.650M
YoY Change -14.73% 13.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $20.87M
YoY Change -100.0% 7.19%
Long-Term Debt Due $17.78M $31.86K
YoY Change 58905.14% 7.49%
Total Short-Term Liabilities $46.63M $47.89M
YoY Change -24.82% -29.57%
LONG-TERM LIABILITIES
Long-Term Debt $67.00K
YoY Change -99.66%
Other Long-Term Liabilities $1.100M $1.479M
YoY Change -93.38% -54.06%
Total Long-Term Liabilities $0.00 $1.546M
YoY Change -100.0% -93.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $46.63M $47.89M
Total Long-Term Liabilities $0.00 $1.546M
Total Liabilities $47.78M $49.44M
YoY Change -45.6% -45.51%
SHAREHOLDERS EQUITY
Retained Earnings -$169.8M -$150.7M
YoY Change 63.52% 81.67%
Common Stock $16.52K $16.46K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $41.73M $56.77M
YoY Change
Total Liabilities & Shareholders Equity $87.84M $104.8M
YoY Change -51.36% -45.39%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$19.05M -$17.34M
YoY Change -8.7% 620.97%
Depreciation, Depletion And Amortization $11.88M $8.790M
YoY Change -26.82% -45.14%
Cash From Operating Activities -$630.0K -$5.509M
YoY Change -92.13% -120.19%
INVESTING ACTIVITIES
Capital Expenditures $400.0K $1.703M
YoY Change -102.5% -107.25%
Acquisitions
YoY Change
Other Investing Activities $150.0K $8.401M
YoY Change -98.91%
Cash From Investing Activities -$260.0K $6.698M
YoY Change -88.75% -128.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -3.230M 3.043M
YoY Change -148.02% -176.62%
NET CHANGE
Cash From Operating Activities -630.0K -5.509M
Cash From Investing Activities -260.0K 6.698M
Cash From Financing Activities -3.230M 3.043M
Net Change In Cash -4.120M 4.231M
YoY Change 14.75% -2399.95%
FREE CASH FLOW
Cash From Operating Activities -$630.0K -$5.509M
Capital Expenditures $400.0K $1.703M
Free Cash Flow -$1.030M -$7.212M
YoY Change -112.86% -114.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.12
CY2023Q2 migi Longterm Borrowings
LongtermBorrowings
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40849
dei Entity Registrant Name
EntityRegistrantName
Mawson Infrastructure Group Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
88-0445167
dei Entity Address Address Line1
EntityAddressAddressLine1
201 Clark Street
dei Entity Address City Or Town
EntityAddressCityOrTown
Sharon
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
16146
dei City Area Code
CityAreaCode
+1-412
dei Local Phone Number
LocalPhoneNumber
-515-0896
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
MIGI
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16518043 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5607254 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
946265 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3584578 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3488868 usd
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
6403552 usd
CY2022Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
10458076 usd
CY2022Q4 us-gaap Assets Held In Trust Current
AssetsHeldInTrustCurrent
5446059 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
15595384 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
20339268 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78529474 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91016498 usd
CY2023Q2 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
5174446 usd
CY2022Q4 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
11299971 usd
CY2023Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
1993837 usd
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
2085373 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3243957 usd
CY2023Q2 us-gaap Security Deposit
SecurityDeposit
424064 usd
CY2022Q4 us-gaap Security Deposit
SecurityDeposit
2524065 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3052978 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2819933 usd
CY2023Q2 us-gaap Assets
Assets
104770183 usd
CY2022Q4 us-gaap Assets
Assets
133329065 usd
CY2023Q2 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
25337339 usd
CY2022Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
10572061 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1649529 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1300062 usd
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
31859 usd
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
30702 usd
CY2023Q2 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
20873805 usd
CY2022Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
23610583 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
47892532 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35513408 usd
CY2022Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
15328445 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1478707 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1727975 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
67000 usd
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
83223 usd
CY2022Q4 migi Longterm Borrowings
LongtermBorrowings
4509894 usd
CY2023Q2 us-gaap Liabilities
Liabilities
49438239 usd
CY2022Q4 us-gaap Liabilities
Liabilities
57162945 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16454709 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16454709 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13625882 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13625882 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
16455 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
13626 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
202136148 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
194294559 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5321282 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
5021467 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-150703559 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-122257628 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
56770326 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
77072024 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
-1438382 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
-905904 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55331944 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
76166120 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104770183 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
133329065 usd
CY2023Q2 us-gaap Revenues
Revenues
10551535 usd
CY2022Q2 us-gaap Revenues
Revenues
19780437 usd
us-gaap Revenues
Revenues
18222142 usd
us-gaap Revenues
Revenues
39204773 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
7028458 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
14359072 usd
us-gaap Cost Of Revenue
CostOfRevenue
11706460 usd
us-gaap Cost Of Revenue
CostOfRevenue
22771433 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
3523077 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
5421365 usd
us-gaap Gross Profit
GrossProfit
6515682 usd
us-gaap Gross Profit
GrossProfit
16433340 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6265256 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
9431088 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11242674 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15908034 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
687276 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
936235 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1691619 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1326844 usd
CY2023Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8789755 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
16023817 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16752279 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
29826849 usd
CY2023Q2 migi Change In Fair Value Of Derivative Asset
ChangeInFairValueOfDerivativeAsset
-5444300 usd
CY2022Q2 migi Change In Fair Value Of Derivative Asset
ChangeInFairValueOfDerivativeAsset
17714357 usd
migi Change In Fair Value Of Derivative Asset
ChangeInFairValueOfDerivativeAsset
-6125525 usd
migi Change In Fair Value Of Derivative Asset
ChangeInFairValueOfDerivativeAsset
17714357 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
21186587 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
8676783 usd
us-gaap Operating Expenses
OperatingExpenses
35812097 usd
us-gaap Operating Expenses
OperatingExpenses
29347370 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-17663510 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3255418 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-29296415 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-12914030 usd
CY2023Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-397165 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1657055 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-815382 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
957818 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
647062 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
1565040 usd
us-gaap Interest Expense
InterestExpense
1546114 usd
us-gaap Interest Expense
InterestExpense
2801713 usd
CY2022Q2 migi Impairment Of Financial Assets
ImpairmentOfFinancialAssets
-1107197 usd
migi Impairment Of Financial Assets
ImpairmentOfFinancialAssets
-1107197 usd
CY2023Q2 migi Loss On Reclassification To Assets Held For Sale
LossOnReclassificationToAssetsHeldForSale
2562283 usd
migi Loss On Reclassification To Assets Held For Sale
LossOnReclassificationToAssetsHeldForSale
3353130 usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
1437230 usd
CY2023Q2 us-gaap Other Income
OtherIncome
252363 usd
CY2022Q2 us-gaap Other Income
OtherIncome
1864968 usd
us-gaap Other Income
OtherIncome
177941 usd
us-gaap Other Income
OtherIncome
1889415 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-36356 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1770419 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
849786 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2570449 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1061677 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15893091 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2405632 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26725966 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13975707 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1756371 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2304454 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-17649462 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-2405632 usd
us-gaap Profit Loss
ProfitLoss
-29030420 usd
us-gaap Profit Loss
ProfitLoss
-13975707 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-305556 usd
CY2022Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-288229 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-584489 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-522648 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-17343906 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2117403 usd
us-gaap Net Income Loss
NetIncomeLoss
-28445931 usd
us-gaap Net Income Loss
NetIncomeLoss
-13453059 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.12
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.12
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15527824 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11933092 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14744915 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11965129 shares
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-17649462 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-2405632 usd
us-gaap Profit Loss
ProfitLoss
-29030420 usd
us-gaap Profit Loss
ProfitLoss
-13975707 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
220093 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2579238 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
351826 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1995930 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-17429369 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4984870 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-28678594 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-15971637 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-305556 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-288229 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-584489 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-522648 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17123813 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4696641 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28094105 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15448989 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
66733521 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
500500 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1 usd
CY2023Q2 migi Stock Issued During Period Value Restricted Stock Units And Options
StockIssuedDuringPeriodValueRestrictedStockUnitsAndOptions
186775 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5340516 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-17649462 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
220093 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55331944 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
103929122 usd
CY2022Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
435734 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
500500 usd
CY2022Q2 migi Stock Issued During Period Value Restricted Stock Units And Options
StockIssuedDuringPeriodValueRestrictedStockUnitsAndOptions
896 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-2405632 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-2579238 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1239792 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
101121174 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
76166120 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
276959 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
63945 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
307069 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1001000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
383550 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5811895 usd
us-gaap Profit Loss
ProfitLoss
-29030420 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
351826 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
55331944 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
114580589 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
543463 usd
us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
667333 usd
migi Stock Issued During Period Value Restricted Stock Units And Options
StockIssuedDuringPeriodValueRestrictedStockUnitsAndOptions
61633 usd
us-gaap Profit Loss
ProfitLoss
-13975707 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1995930 usd
us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
1239793 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
101121174 usd
us-gaap Profit Loss
ProfitLoss
-29030420 usd
us-gaap Profit Loss
ProfitLoss
-13975707 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
16752279 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29826849 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
678310 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
809130 usd
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
751833 usd
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
137758 usd
us-gaap Gain Loss On Sale Of Project
GainLossOnSaleOfProject
1465829 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1691619 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1326844 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
866691 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
138293 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-6125525 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
17714357 usd
migi Noncontrolling Interest
NoncontrollingInterest
1239793 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
1437230 usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-36122 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-158023 usd
migi Loss On Write Off Of Property And Equipment
LossOnWriteOffOfPropertyAndEquipment
73243 usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
3353130 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1808709 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-1394878 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-807136 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2004290 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
7869996 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-511208 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
39299304 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4192480 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33146960 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4851771 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21100867 usd
migi Proceeds From Sale Of Site
ProceedsFromSaleOfSite
8107508 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
584301 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
6927003 usd
migi Payment Of Property And Equipment Deposits
PaymentOfPropertyAndEquipmentDeposits
32054326 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10767041 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-53155193 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6192845 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
51524 usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
380950 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
1986870 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
26581467 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
19088 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
937008 usd
migi Payments Of Borrowings
PaymentsOfBorrowings
9672854 usd
migi Payments Of Borrowings
PaymentsOfBorrowings
6182245 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1893177 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
19513738 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-20395 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2478952 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4660989 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2973447 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
946265 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5467273 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5607254 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2493826 usd
migi Recognition Of Right Of Use Operating Asset And Lease Liability
RecognitionOfRightOfUseOperatingAssetAndLeaseLiability
911356 usd
us-gaap Stock Issued1
StockIssued1
276959 usd
us-gaap Impaired Intangible Asset Description
ImpairedIntangibleAssetDescription
Mawson owned 23,458 Application-Specific Integrated Circuit (“ASIC”) computers known as “Miners,” specifically focused on the SHA-256 algorithm.
us-gaap Taxes Other
TaxesOther
29030000.00 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
32300000 usd
CY2023Q2 us-gaap Assets Net
AssetsNet
55330000 usd
CY2023Q2 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
150700000 usd
CY2023Q2 us-gaap Cash Available For Distributions
CashAvailableForDistributions
5610000 usd
migi Bitcoin Price Amount
BitcoinPriceAmount
30000 usd
CY2023Q2 migi Bitcoin Trending Higher Percentage
BitcoinTrendingHigherPercentage
0.70 pure
CY2023Q2 us-gaap Secured Long Term Debt
SecuredLongTermDebt
20000000 usd
us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
3330000 usd
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
1460000 aud
CY2023Q2 us-gaap Line Of Credit
LineOfCredit
970000 usd
CY2023Q2 us-gaap Security Deposit Liability
SecurityDepositLiability
500000 usd
CY2023Q2 us-gaap Shares Issued
SharesIssued
100000 shares
us-gaap Stock Issued During Period Shares Stock Splits
StockIssuedDuringPeriodSharesStockSplits
10 shares
migi Percentage Of Outstanding Shares
PercentageOfOutstandingShares
0.05 pure
CY2023Q1 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
Mawson executed a reverse stock split of its outstanding common stock at a ratio of 1:6
CY2023Q1 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
90000000 shares
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates and Assumptions</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with U.S. GAAP requires management to make estimates, judgments and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of income and expenses during the reporting periods. Actual results could differ from those estimates. The Company has considered the following to be significant estimates made by management, including but not limited to, going concern assumptions, estimating the useful lives of fixed assets, realization of long-lived assets, unrealized tax positions and the realization of digital currencies, valuing the derivative asset classified under Level 3 fair value hierarchy, business combinations and the contingent obligation with respect to future revenues.</span></p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reclassifications</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain reclassifications of prior period amounts have been made to conform to current period presentation.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
5174446 usd
CY2022Q4 us-gaap Derivative Assets Noncurrent
DerivativeAssetsNoncurrent
11299971 usd
CY2022Q4 us-gaap Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
3243957 usd
CY2023Q2 us-gaap Lessee Finance Lease Discount Rate
LesseeFinanceLeaseDiscountRate
0.20 pure
CY2023Q2 us-gaap Shares Issued
SharesIssued
10000000 shares
migi Treasury Bond Term
TreasuryBondTerm
P10Y
CY2023Q1 migi Digital Currencies Balance
DigitalCurrenciesBalance
1.02
CY2022Q4 migi Digital Currencies Balance
DigitalCurrenciesBalance
0
CY2023Q2 migi Additions Of Digital Currencies1
AdditionsOfDigitalCurrencies1
181.62
migi Additions Of Digital Currencies1
AdditionsOfDigitalCurrencies1
302.73
CY2023Q2 migi Sale Of Digital Currencies1
SaleOfDigitalCurrencies1
-182.64
migi Sale Of Digital Currencies1
SaleOfDigitalCurrencies1
-302.73
CY2023Q2 migi Digital Currencies Balance
DigitalCurrenciesBalance
0
CY2023Q2 migi Digital Currencies Balance
DigitalCurrenciesBalance
0
migi Warrants To Purchase Common Stocks
WarrantsToPurchaseCommonStocks
5546122 shares
migi Warrants To Purchase Common Stocks
WarrantsToPurchaseCommonStocks
1065278 shares
migi Options To Purchase Common Stock
OptionsToPurchaseCommonStock
1750417 shares
migi Options To Purchase Common Stock
OptionsToPurchaseCommonStock
4910 shares
migi Restricted Stock Units Rs Us Issued Under A Management Equity Plan
RestrictedStockUnitsRSUsIssuedUnderAManagementEquityPlan
4443516 shares
migi Restricted Stock Units Rs Us Issued Under A Management Equity Plan
RestrictedStockUnitsRSUsIssuedUnderAManagementEquityPlan
408288 shares
migi Total Of Diluted Loss Per Share
TotalOfDilutedLossPerShare
11740055 shares
migi Total Of Diluted Loss Per Share
TotalOfDilutedLossPerShare
1478476 shares
us-gaap Lessor Operating Lease Option To Extend
LessorOperatingLeaseOptionToExtend
The term of the lease is for four years, with an option to extend for five years.
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
8143 usd
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
8094 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
16287 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
12396 usd
CY2023Q2 migi Interest On Lease Obligations1
InterestOnLeaseObligations1
1310 usd
CY2022Q2 migi Interest On Lease Obligations1
InterestOnLeaseObligations1
2468 usd
migi Interest On Lease Obligations1
InterestOnLeaseObligations1
4021 usd
migi Interest On Lease Obligations1
InterestOnLeaseObligations1
3946 usd
CY2023Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4133322 shares
us-gaap Labor And Related Expense
LaborAndRelatedExpense
48223 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
25167 usd
us-gaap Insurance Agency Management Fee
InsuranceAgencyManagementFee
363611 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
149019843 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
145506464 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
70490369 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
54489966 usd
CY2023Q2 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
78529474 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
91016498 usd
CY2023Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
8790000 usd
CY2022Q2 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
16020000.00 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
16750000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
29830000 usd
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Long Term Debt Average Amount Outstanding
LongTermDebtAverageAmountOutstanding
8070000.00 usd
us-gaap Interest Paid
InterestPaid
500000 usd
CY2023Q1 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.15 pure
CY2022Q3 us-gaap Debt Instrument Description
DebtInstrumentDescription
On September 2, 2022, MIG PL entered into a Secured Loan Facility Agreement with W Capital Advisors Pty Ltd with a total loan facility of AUD$3.00 million (USD$1.9 million). This was amended on September 29, 2022 and the loan facility was increased to AUD$8.00 million (USD$5.2 million). During the six month period ending June 30, 2023, the Company received AUD$3.00 million (USD$1.99 million) from this loan facility. As at June 30, 2023, AUD$1.46 million (USD$0.97 million) has been drawn down from this facility, all of which is classified as a current liability.
CY2023Q2 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.12 pure
CY2022Q3 us-gaap Debt Instrument Periodic Payment Principal
DebtInstrumentPeriodicPaymentPrincipal
3.6 usd
CY2022Q4 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
3100000 usd
CY2023Q2 migi Total Stockbased Compensation
TotalStockbasedCompensation
687276 shares
CY2022Q2 migi Total Stockbased Compensation
TotalStockbasedCompensation
936234 shares
migi Total Stockbased Compensation
TotalStockbasedCompensation
1691619 shares
migi Total Stockbased Compensation
TotalStockbasedCompensation
1326843 shares
CY2023Q2 migi Cost Related To The Performance Based Awards
CostRelatedToThePerformanceBasedAwards
700000 usd
CY2023Q2 migi Cost Related To The Service Based Restricted Stock Awards
CostRelatedToTheServiceBasedRestrictedStockAwards
7830000 usd
CY2023Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
1350000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
417 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.9
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P1Y3M3D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1750000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.89
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1750417 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.9
migi Sharebased Compensations Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationsArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P10Y
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
417 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
35.9
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y3M3D
us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
10124 usd
CY2023Q2 migi Cost Related To The Warrants Issued
CostRelatedToTheWarrantsIssued
800000 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.4
CY2023Q2 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
246668 shares
CY2023Q2 us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
0.001
CY2023Q2 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
3.23
CY2023Q2 migi Exercise Price Per Share
ExercisePricePerShare
3
migi Purchase An Aggregate
PurchaseAnAggregate
1666667 shares
us-gaap Warrant Exercise Price Decrease
WarrantExercisePriceDecrease
6.06
us-gaap Warrant Exercise Price Increase
WarrantExercisePriceIncrease
3.23
CY2023Q2 migi Purchase Price
purchasePrice
2.4
CY2023Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Net
DebtIssuanceCostsLineOfCreditArrangementsNet
4600000 usd
CY2023Q2 migi Aggregate Offering Price
AggregateOfferingPrice
9000000 usd
us-gaap Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds
DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds
721460 usd
migi Exercises Of Restricted Stock
ExercisesOfRestrictedStock
656 shares
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
186776 usd
CY2022Q1 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2022Q1 migi Lease Extend Term
LeaseExtendTerm
P5Y
CY2022Q1 migi Rent Expenses Percentage
RentExpensesPercentage
0.04 pure
CY2022Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
240000 usd
us-gaap Cost Maintenance
CostMaintenance
154224 usd
us-gaap Cost Maintenance
CostMaintenance
102750 usd
us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
42741 usd
us-gaap Insurance Agency Management Fee
InsuranceAgencyManagementFee
262802 usd
migi Vehicle Service Amount
VehicleServiceAmount
35495 usd
migi Vehicle Service Amount
VehicleServiceAmount
41525 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
841042 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
4464097 usd
CY2023Q2 migi Impairment Of Financial Assets
ImpairmentOfFinancialAssets
usd
migi Impairment Of Financial Assets
ImpairmentOfFinancialAssets
usd
CY2022Q2 migi Loss On Reclassification To Assets Held For Sale
LossOnReclassificationToAssetsHeldForSale
usd
migi Loss On Reclassification To Assets Held For Sale
LossOnReclassificationToAssetsHeldForSale
usd
CY2023Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
CY2022Q2 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.12
us-gaap Gain Loss On Sale Of Project
GainLossOnSaleOfProject
usd
migi Noncontrolling Interest
NoncontrollingInterest
usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
usd
us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
migi Loss On Write Off Of Property And Equipment
LossOnWriteOffOfPropertyAndEquipment
usd
us-gaap Gain Loss On Sale Of Properties
GainLossOnSaleOfProperties
usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
usd
migi Proceeds From Sale Of Site
ProceedsFromSaleOfSite
usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
migi Payment Of Property And Equipment Deposits
PaymentOfPropertyAndEquipmentDeposits
usd
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
usd
migi Recognition Of Right Of Use Operating Asset And Lease Liability
RecognitionOfRightOfUseOperatingAssetAndLeaseLiability
usd
us-gaap Stock Issued1
StockIssued1
usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001218683

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
migi-20230630_def.xml Edgar Link unprocessable
0001213900-23-069345-index-headers.html Edgar Link pending
0001213900-23-069345-index.html Edgar Link pending
0001213900-23-069345.txt Edgar Link pending
0001213900-23-069345-xbrl.zip Edgar Link pending
f10q0623ex3-8_mawson.htm Edgar Link pending
f10q0623ex31-1_mawson.htm Edgar Link pending
f10q0623ex31-2_mawson.htm Edgar Link pending
f10q0623ex32_mawson.htm Edgar Link pending
f10q0623_mawson.htm Edgar Link pending
f10q0623_mawson_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
migi-20230630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
migi-20230630_cal.xml Edgar Link unprocessable
migi-20230630_lab.xml Edgar Link unprocessable
migi-20230630_pre.xml Edgar Link unprocessable
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending